1-3 of 3
Mary T. Brophy
Close
Sort by
Journal Articles

Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders

Clinical Trials & Observations
Nathanael R. Fillmore, Jennifer La, Julie Tsu-Yu Wu, June K. Corrigan, Westyn Branch-Elliman, Paul Monach, Mary T. Brophy, Nhan V. Do, Nikhil C. Munshi
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6767–6770.
https://doi.org/10.1182/bloodadvances.2023011063
Published: 2023
Journal Articles

Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study

Clinical Trials & Observations
Nathanael R. Fillmore, Diana Cirstea, Anusha Munjuluri, Hassan Yameen, Sarvari V. Yellapragada, Nhan V. Do, Mary T. Brophy, Raphael E. Szalat, Nikhil C. Munshi
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3511–3514.
https://doi.org/10.1182/bloodadvances.2020004001
Published: 2021
Journal Articles

Vitamin D deficiency predicts for poor overall survival in white but not African American patients with multiple myeloma

Clinical Trials & Observations
Sarvari V. Yellapragada, Nathanael R. Fillmore, Anna Frolov, Yang Zhou, Pallavi Dev, Hassan Yameen, Chizoba Ifeorah, Nhan V. Do, Mary T. Brophy, Nikhil C. Munshi
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1643–1646.
https://doi.org/10.1182/bloodadvances.2019001411
Published: 2020